▶ 調査レポート

睡眠薬(処方薬)の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Sleeping Pills (Prescription Drugs) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。睡眠薬(処方薬)の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Sleeping Pills (Prescription Drugs) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-14119資料のイメージです。• レポートコード:D005-14119
• 出版社/出版日:GlobalInfoResearch / 2020年5月26日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、睡眠薬(処方薬)の世界市場を広く調査・分析し、今後の市場展望をまとめております。睡眠薬(処方薬)の種類別市場規模(ゾルピデム、エスゾピクロン(ルネスタ)、ラメルテオン(ロゼレム)、アティバン(ロラゼパム)、アダピン(ドキセピン))、用途別市場規模(病院薬局、小売薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Sanofi、Cayman Chemical、Apotex、Abbott Laboratories、Allegiant Health、Takeda Pharmaceutical、Hayao、Actellon Pharmaceuticals、Aurobindo Pharma、Ambitropin
・地域別グローバル市場分析 2015年-2020年
・睡眠薬(処方薬)の北米市場(アメリカ、カナダ、メキシコ)
・睡眠薬(処方薬)のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・睡眠薬(処方薬)のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・睡眠薬(処方薬)の南米市場(ブラジル、アルゼンチン)
・睡眠薬(処方薬)の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ゾルピデム、エスゾピクロン(ルネスタ)、ラメルテオン(ロゼレム)、アティバン(ロラゼパム)、アダピン(ドキセピン)
・用途別分析:病院薬局、小売薬局
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Sleeping Pills (Prescription Drugs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Sleeping Pills (Prescription Drugs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Sleeping Pills (Prescription Drugs) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Sleeping Pills (Prescription Drugs) market has been segmented into
Zolpidem
Eszopiclone (Lunesta)
Ramelteon (Rozerem)
Ativan (lorazepam)
Adapin (doxepin)

By Application, Sleeping Pills (Prescription Drugs) has been segmented into:
Hospital Pharmacy
Retail Pharmacy

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sleeping Pills (Prescription Drugs) market presented in the report. This section sheds light on the sales growth of different regional and country-level Sleeping Pills (Prescription Drugs) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sleeping Pills (Prescription Drugs) market.

The report offers in-depth assessment of the growth and other aspects of the Sleeping Pills (Prescription Drugs) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Sleeping Pills (Prescription Drugs) Market Share Analysis
Sleeping Pills (Prescription Drugs) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sleeping Pills (Prescription Drugs) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sleeping Pills (Prescription Drugs) sales, revenue and market share for each player covered in this report.

The major players covered in Sleeping Pills (Prescription Drugs) are:
Sanofi
Cayman Chemical
Apotex
Abbott Laboratories
Allegiant Health
Takeda Pharmaceutical
Hayao
Actellon Pharmaceuticals
Aurobindo Pharma
Ambitropin

Among other players domestic and global, Sleeping Pills (Prescription Drugs) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sleeping Pills (Prescription Drugs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sleeping Pills (Prescription Drugs), with price, sales, revenue and global market share of Sleeping Pills (Prescription Drugs) in 2018 and 2019.
Chapter 3, the Sleeping Pills (Prescription Drugs) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sleeping Pills (Prescription Drugs) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Sleeping Pills (Prescription Drugs) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Sleeping Pills (Prescription Drugs) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Sleeping Pills (Prescription Drugs) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sleeping Pills (Prescription Drugs) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Zolpidem
1.2.3 Eszopiclone (Lunesta)
1.2.4 Ramelteon (Rozerem)
1.2.5 Ativan (lorazepam)
1.2.6 Adapin (doxepin)
1.3 Market Analysis by Application
1.3.1 Overview: Global Sleeping Pills (Prescription Drugs) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Overview of Global Sleeping Pills (Prescription Drugs) Market
1.4.1 Global Sleeping Pills (Prescription Drugs) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cayman Chemical
2.2.1 Cayman Chemical Details
2.2.2 Cayman Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cayman Chemical SWOT Analysis
2.2.4 Cayman Chemical Product and Services
2.2.5 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Apotex
2.3.1 Apotex Details
2.3.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Apotex SWOT Analysis
2.3.4 Apotex Product and Services
2.3.5 Apotex Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott Laboratories SWOT Analysis
2.4.4 Abbott Laboratories Product and Services
2.4.5 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Allegiant Health
2.5.1 Allegiant Health Details
2.5.2 Allegiant Health Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Allegiant Health SWOT Analysis
2.5.4 Allegiant Health Product and Services
2.5.5 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Takeda Pharmaceutical
2.6.1 Takeda Pharmaceutical Details
2.6.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Takeda Pharmaceutical SWOT Analysis
2.6.4 Takeda Pharmaceutical Product and Services
2.6.5 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hayao
2.7.1 Hayao Details
2.7.2 Hayao Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hayao SWOT Analysis
2.7.4 Hayao Product and Services
2.7.5 Hayao Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Actellon Pharmaceuticals
2.8.1 Actellon Pharmaceuticals Details
2.8.2 Actellon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Actellon Pharmaceuticals SWOT Analysis
2.8.4 Actellon Pharmaceuticals Product and Services
2.8.5 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Aurobindo Pharma
2.9.1 Aurobindo Pharma Details
2.9.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Aurobindo Pharma SWOT Analysis
2.9.4 Aurobindo Pharma Product and Services
2.9.5 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ambitropin
2.10.1 Ambitropin Details
2.10.2 Ambitropin Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Ambitropin SWOT Analysis
2.10.4 Ambitropin Product and Services
2.10.5 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Sleeping Pills (Prescription Drugs) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Sleeping Pills (Prescription Drugs) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sleeping Pills (Prescription Drugs) Manufacturer Market Share in 2019
3.3.2 Top 6 Sleeping Pills (Prescription Drugs) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Sleeping Pills (Prescription Drugs) Sales, Revenue and Market Share by Regions
4.1.1 Global Sleeping Pills (Prescription Drugs) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Sleeping Pills (Prescription Drugs) Revenue and Market Share by Regions (2015-2020)
4.2 North America Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
4.3 Europe Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
4.5 South America Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Sleeping Pills (Prescription Drugs) Sales, Revenue and Market Share by Country
5.1.1 North America Sleeping Pills (Prescription Drugs) Sales and Market Share by Country (2015-2020)
5.1.2 North America Sleeping Pills (Prescription Drugs) Revenue and Market Share by Country (2015-2020)
5.2 United States Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
5.3 Canada Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
5.4 Mexico Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Sleeping Pills (Prescription Drugs) Sales, Revenue and Market Share by Country
6.1.1 Europe Sleeping Pills (Prescription Drugs) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Sleeping Pills (Prescription Drugs) Revenue and Market Share by Country (2015-2020)
6.2 Germany Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
6.3 UK Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
6.4 France Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
6.5 Russia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
6.6 Italy Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Sleeping Pills (Prescription Drugs) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Sleeping Pills (Prescription Drugs) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Sleeping Pills (Prescription Drugs) Revenue and Market Share by Regions (2015-2020)
7.2 China Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
7.3 Japan Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
7.4 Korea Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
7.5 India Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
7.7 Australia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Sleeping Pills (Prescription Drugs) Sales, Revenue and Market Share by Country
8.1.1 South America Sleeping Pills (Prescription Drugs) Sales and Market Share by Country (2015-2020)
8.1.2 South America Sleeping Pills (Prescription Drugs) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
8.3 Argentina Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Sleeping Pills (Prescription Drugs) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Sleeping Pills (Prescription Drugs) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Sleeping Pills (Prescription Drugs) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
9.3 Turkey Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
9.4 Egypt Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
9.5 South Africa Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Sleeping Pills (Prescription Drugs) Sales and Market Share by Type (2015-2020)
10.2 Global Sleeping Pills (Prescription Drugs) Revenue and Market Share by Type (2015-2020)
10.3 Global Sleeping Pills (Prescription Drugs) Price by Type (2015-2020)
11 Global Sleeping Pills (Prescription Drugs) Market Segment by Application
11.1 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2015-2020)
11.2 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2015-2020)
11.3 Global Sleeping Pills (Prescription Drugs) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Sleeping Pills (Prescription Drugs) Sales, Revenue and Growth Rate (2021-2025)
12.2 Sleeping Pills (Prescription Drugs) Market Forecast by Regions (2021-2025)
12.2.1 North America Sleeping Pills (Prescription Drugs) Market Forecast (2021-2025)
12.2.2 Europe Sleeping Pills (Prescription Drugs) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Sleeping Pills (Prescription Drugs) Market Forecast (2021-2025)
12.2.4 South America Sleeping Pills (Prescription Drugs) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Sleeping Pills (Prescription Drugs) Market Forecast (2021-2025)
12.3 Sleeping Pills (Prescription Drugs) Market Forecast by Type (2021-2025)
12.3.1 Global Sleeping Pills (Prescription Drugs) Sales Forecast by Type (2021-2025)
12.3.2 Global Sleeping Pills (Prescription Drugs) Market Share Forecast by Type (2021-2025)
12.4 Sleeping Pills (Prescription Drugs) Market Forecast by Application (2021-2025)
12.4.1 Global Sleeping Pills (Prescription Drugs) Sales Forecast by Application (2021-2025)
12.4.2 Global Sleeping Pills (Prescription Drugs) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Sleeping Pills (Prescription Drugs) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sleeping Pills (Prescription Drugs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sleeping Pills (Prescription Drugs) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Sleeping Pills (Prescription Drugs) Major Business
Table 9. Sanofi Sleeping Pills (Prescription Drugs) Total Revenue (USD Million) (2018-2019)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Sleeping Pills (Prescription Drugs) Product and Services
Table 12. Sanofi Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Cayman Chemical Basic Information, Manufacturing Base and Competitors
Table 14. Cayman Chemical Sleeping Pills (Prescription Drugs) Major Business
Table 15. Cayman Chemical Sleeping Pills (Prescription Drugs) Total Revenue (USD Million) (2018-2019)
Table 16. Cayman Chemical SWOT Analysis
Table 17. Cayman Chemical Sleeping Pills (Prescription Drugs) Product and Services
Table 18. Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Apotex Basic Information, Manufacturing Base and Competitors
Table 20. Apotex Sleeping Pills (Prescription Drugs) Major Business
Table 21. Apotex Sleeping Pills (Prescription Drugs) Total Revenue (USD Million) (2018-2019)
Table 22. Apotex SWOT Analysis
Table 23. Apotex Sleeping Pills (Prescription Drugs) Product and Services
Table 24. Apotex Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 26. Abbott Laboratories Sleeping Pills (Prescription Drugs) Major Business
Table 27. Abbott Laboratories Sleeping Pills (Prescription Drugs) Total Revenue (USD Million) (2018-2019)
Table 28. Abbott Laboratories SWOT Analysis
Table 29. Abbott Laboratories Sleeping Pills (Prescription Drugs) Product and Services
Table 30. Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Allegiant Health Basic Information, Manufacturing Base and Competitors
Table 32. Allegiant Health Sleeping Pills (Prescription Drugs) Major Business
Table 33. Allegiant Health Sleeping Pills (Prescription Drugs) Total Revenue (USD Million) (2018-2019)
Table 34. Allegiant Health SWOT Analysis
Table 35. Allegiant Health Sleeping Pills (Prescription Drugs) Product and Services
Table 36. Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Major Business
Table 39. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Total Revenue (USD Million) (2018-2019)
Table 40. Takeda Pharmaceutical SWOT Analysis
Table 41. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product and Services
Table 42. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Hayao Basic Information, Manufacturing Base and Competitors
Table 44. Hayao Sleeping Pills (Prescription Drugs) Major Business
Table 45. Hayao Sleeping Pills (Prescription Drugs) Total Revenue (USD Million) (2018-2019)
Table 46. Hayao SWOT Analysis
Table 47. Hayao Sleeping Pills (Prescription Drugs) Product and Services
Table 48. Hayao Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Actellon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Major Business
Table 51. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Total Revenue (USD Million) (2018-2019)
Table 52. Actellon Pharmaceuticals SWOT Analysis
Table 53. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product and Services
Table 54. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Major Business
Table 57. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Total Revenue (USD Million) (2018-2019)
Table 58. Aurobindo Pharma SWOT Analysis
Table 59. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product and Services
Table 60. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Ambitropin Basic Information, Manufacturing Base and Competitors
Table 62. Ambitropin Sleeping Pills (Prescription Drugs) Major Business
Table 63. Ambitropin Sleeping Pills (Prescription Drugs) Total Revenue (USD Million) (2018-2019)
Table 64. Ambitropin SWOT Analysis
Table 65. Ambitropin Sleeping Pills (Prescription Drugs) Product and Services
Table 66. Ambitropin Sleeping Pills (Prescription Drugs) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Sleeping Pills (Prescription Drugs) Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Sleeping Pills (Prescription Drugs) Sales by Regions (2015-2020) (K Units)
Table 70. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Regions (2015-2020)
Table 71. Global Sleeping Pills (Prescription Drugs) Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Sleeping Pills (Prescription Drugs) Sales by Countries (2015-2020) (K Units)
Table 73. North America Sleeping Pills (Prescription Drugs) Sales Market Share by Countries (2015-2020)
Table 74. North America Sleeping Pills (Prescription Drugs) Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2015-2020)
Table 76. Europe Sleeping Pills (Prescription Drugs) Sales by Countries (2015-2020) (K Units)
Table 77. Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Countries (2015-2020)
Table 78. Europe Sleeping Pills (Prescription Drugs) Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Sleeping Pills (Prescription Drugs) Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Sleeping Pills (Prescription Drugs) Sales by Countries (2015-2020) (K Units)
Table 83. South America Sleeping Pills (Prescription Drugs) Sales Market Share by Countries (2015-2020)
Table 84. South America Sleeping Pills (Prescription Drugs) Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Sleeping Pills (Prescription Drugs) Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2015-2020)
Table 90. Global Sleeping Pills (Prescription Drugs) Sales by Type (2015-2020) (K Units)
Table 91. Global Sleeping Pills (Prescription Drugs) Sales Share by Type (2015-2020)
Table 92. Global Sleeping Pills (Prescription Drugs) Revenue by Type (2015-2020) (USD Million)
Table 93. Global Sleeping Pills (Prescription Drugs) Revenue Share by Type (2015-2020)
Table 94. Global Sleeping Pills (Prescription Drugs) Sales by Application (2015-2020) (K Units)
Table 95. Global Sleeping Pills (Prescription Drugs) Sales Share by Application (2015-2020)
Table 96. Global Sleeping Pills (Prescription Drugs) Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Sleeping Pills (Prescription Drugs) Market Share Forecast by Regions (2021-2025)
Table 98. Global Sleeping Pills (Prescription Drugs) Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Sleeping Pills (Prescription Drugs) Market Share Forecast by Type (2021-2025)
Table 100. Global Sleeping Pills (Prescription Drugs) Sales Forecast by Application (2021-2025)
Table 101. Global Sleeping Pills (Prescription Drugs) Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Sleeping Pills (Prescription Drugs) Picture
Figure 2. Global Sales Market Share of Sleeping Pills (Prescription Drugs) by Type in 2019
Figure 3. Zolpidem Picture
Figure 4. Eszopiclone (Lunesta) Picture
Figure 5. Ramelteon (Rozerem) Picture
Figure 6. Ativan (lorazepam) Picture
Figure 7. Adapin (doxepin) Picture
Figure 8. Sleeping Pills (Prescription Drugs) Sales Market Share by Application in 2018
Figure 9. Hospital Pharmacy Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Global Sleeping Pills (Prescription Drugs) Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Sleeping Pills (Prescription Drugs) Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Manufacturer in 2019
Figure 32. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Sleeping Pills (Prescription Drugs) Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Sleeping Pills (Prescription Drugs) Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Regions (2015-2020)
Figure 39. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Regions in 2018
Figure 40. North America Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
Figure 41. Europe Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
Figure 43. South America Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020)
Figure 45. North America Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Sleeping Pills (Prescription Drugs) Sales Market Share by Countries (2015-2020)
Figure 47. North America Sleeping Pills (Prescription Drugs) Sales Market Share by Countries in 2018
Figure 48. North America Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries in 2018
Figure 50. United States Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries in 2019
Figure 56. Germany Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Sleeping Pills (Prescription Drugs) Revenue Market Share by Regions 2019
Figure 64. China Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Sleeping Pills (Prescription Drugs) Sales Market Share by Countries in 2019
Figure 71. South America Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries in 2019
Figure 72. Brazil Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Sleeping Pills (Prescription Drugs) Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Sleeping Pills (Prescription Drugs) Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Sleeping Pills (Prescription Drugs) Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Sleeping Pills (Prescription Drugs) Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Sleeping Pills (Prescription Drugs) Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel